APA (7th ed.) Citation

Han, X., Zhang, Y., Li, Y., Lin, Z., Fu, Z., Wang, C., . . . Li, C. (2024). MCL restrained ROS/AKT/ASAH1 pathway to therapy tamoxifen resistance breast cancer by stabilizing NRF2. Cell Proliferation, 57(11), 1. https://doi.org/10.1111/cpr.13700

Chicago Style (17th ed.) Citation

Han, Xiao, Yupeng Zhang, Yin Li, Zhoujun Lin, Zhenkun Fu, Changjun Wang, Shengjie Zhang, Di Shao, and Chenggang Li. "MCL Restrained ROS/AKT/ASAH1 Pathway to Therapy Tamoxifen Resistance Breast Cancer by Stabilizing NRF2." Cell Proliferation 57, no. 11 (2024): 1. https://doi.org/10.1111/cpr.13700.

MLA (9th ed.) Citation

Han, Xiao, et al. "MCL Restrained ROS/AKT/ASAH1 Pathway to Therapy Tamoxifen Resistance Breast Cancer by Stabilizing NRF2." Cell Proliferation, vol. 57, no. 11, 2024, p. 1, https://doi.org/10.1111/cpr.13700.